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Neurotrophins mediate neuronal growth, differentiation, and survival via tropomyosin recep-
tor kinase (Trk) or p75 neurotrophin receptor (p75NTR) signaling. The p75NTR is not exclu-
sively expressed by neurons but also by certain immune cells, implying a role for
neurotrophin signaling in the immune system. In this study, we investigated the effect of
p75NTR on innate immune cell behavior and on neuronal morphology upon chronic Toxo-
plasma gondii (T. gondii) infection-induced neuroinflammation. Characterization of the immune
cells in the periphery and central nervous system (CNS) revealed that innate immune cell sub-
sets in the brain upregulated p75NTR upon infection in wild-type mice. Although cell recruit-
ment and phagocytic capacity of p75NTRexonIV knockout (p75−/−) mice were not impaired, the
activation status of resident microglia and recruited myeloid cell subsets was altered. Impor-
tantly, recruited mononuclear cells in brains of infected p75−/− mice upregulated the produc-
tion of the cytokines interleukin (IL)-10, IL-6 as well as IL-1α. Protein levels of proBDNF,
known to negatively influence neuronal morphology by binding p75NTR, were highly increased
upon chronic infection in the brain of wild-type and p75−/− mice. Moreover, upon infection
the activated immune cells contributed to the proBDNF release. Notably, the
neuroinflammation-induced changes in spine density were rescued in the p75−/− mice. In
conclusion, these findings indicate that neurotrophin signaling via the p75NTR affects innate
immune cell behavior, thus, influencing the structural plasticity of neurons under inflammatory
conditions.
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1 | INTRODUCTION
Neuronal growth, differentiation, survival, and function are orchestrated
in the central nervous system (CNS) by neurotrophins—secreted proteins
involved in shaping neuronal connectivity and in repairing the CNS after
injury (Kaplan & Miller, 2000). Neurotrophins are initially synthesized as
pro-neurotrophins and then cleaved to produce mature proteins. The
family of mature neurotrophins includes nerve growth factor (NGF), brain
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derived neurotrophic factor (BDNF), Neurotrophin-3 (NT-3), and
Neurotrophin-4/5 (NT-4/5). They signal through the tropomyosin recep-
tor kinase (Trk) receptors TrkA, TrkB, TrkC, and the p75 neurotrophin
receptor (p75NTR) being a member of the tumor necrosis factor (TNF)
receptor family. Neurotrophins are critical mediators of neuronal survival
(Chao, 2003). They regulate both the architecture and plasticity of
mature CNS neurons and are necessary for learning processes
(Zagrebelsky & Korte, 2014). Recently, also the role and function of neu-
rotrophin precursors have been explored with more detail suggesting
their important role in injury and disease (Ibáñez & Simi, 2012). Several
studies have described that pro-neurotrophins such as proBDNF bind to
a heterodimeric receptor complex of p75NTR and sortilin with high affin-
ity inducing cell death and reduced synaptic function (Lee, Kermani,
Teng, & Hempstead, 2001; Nykjaer, Willnow, & Petersen, 2005; Woo
et al., 2005; Yang et al., 2014). Notably, mature neurotrophins can also
influence the immune system, however, little is known about the specific
functions in this context. They have been shown to modulate monocyte
chemotaxis, to participate in tissue-healing mechanism, suppression of
nitric oxide release by microglia (Samah, Porcheray, & Gras, 2008) and to
enhance macrophage phagocytic activity (Hashimoto et al., 2005). BDNF
produced by microglia cells and T cells (Kruse, Cetin, Chan, Gold, & Lüh-
der, 2007) was able to modulate monocyte and macrophage function,
for example, by regulating their differentiation towards tissue macro-
phages. Vega et al. detected that NGF and BDNF influenced cytokine
expression in peripheral blood mononuclear cells (Vega, Garcia-Suarez,
Hannestad, Perez-Perez, & Germana, 2003). Furthermore, the condi-
tional depletion of hippocampal BDNF decreased the number of cortical
microglia (Braun, Kalinin, & Feinstein, 2017). In this context, p75NTR is of
special interest. It is expressed by neurons and also by certain types of
immune cells, thus, possibly mediating the interaction between cells of
the CNS and the innate immune system under pathological conditions
(Meeker & Williams, 2014). However, the role of p75NTR signaling in
neuro-immuno-interactions during neuroinflammation has still not been
fully elucidated.
The intracellular parasite Toxoplasma gondii (T. gondii) infects a
wide range of hosts worldwide (Hill, Chirukandoth, & Dubey, 2005;
Montoya & Liesenfeld, 2004; Munoz, Liesenfeld, & Heimesaat, 2011).
Being able to infect all nucleated cells, T. gondii spreads throughout
the host's body during the acute phase of infection. Eventually, the
parasites reach immune-privileged regions such as the CNS. During
the chronic phase of infection cysts are predominantly formed in
infected neurons enabling the parasites to persist lifelong within the
host (Dubey, 1998; Wilson & Hunter, 2004). Chronic infection with
T. gondii is followed by a Th1 type inflammatory response and cell
recruitment to the brain (Biswas et al., 2017; Blanchard, Dunay, &
Schlüter, 2015).
Basal neuroinflammation is associated with the latent infection
(Hermes et al., 2008). Behavioral changes were reported in T. gondii-
infected mice, however, the underlying mechanisms are not fully
understood (Parlog et al., 2014; Parlog, Schlüter, & Dunay, 2015;
Vyas, Kim, Giacomini, Boothroyd, & Sapolsky, 2007). Several factors
may be responsible for these alterations such as the specific neuroin-
flammatory milieu, changes in the neurotransmitter balance affecting
neuronal connectivity, or possibly the preference of cysts to specific
neuron subtypes. Over the past decades, chronic Toxoplasma
infection-induced neuroinflammation has been studied extensively
and can, therefore, be employed as a suitable model to investigate
immune cell dynamics in the CNS and the interaction between
immune cells and neurons.
In a previous study, our research group could highlight the dis-
tinct alterations in cortical and hippocampal neurons of mice chroni-
cally infected with T. gondii (Parlog et al., 2014) showing reduced
neuronal connectivity, decreased dendritic complexity, and changes
in the synaptic protein expression upon infection. Recently, we fur-
ther revealed the alterations in the synaptic protein composition
induced by chronic T. gondii infection (Lang et al., 2018). Moreover,
our group was able to show the crucial involvement in host defense
by recruited myeloid-derived mononuclear cell subsets to the brain
upon chronic toxoplasmosis in addition to tissue resident microglia
(Biswas et al., 2015; Möhle et al., 2016; Möhle, Parlog, Pahnke, &
Dunay, 2014).
In this study, we set out to investigate the impact of p75NTR sig-
naling on the function of immune cells during cerebral toxoplasmo-
sis and to elucidate the role of p75NTR in mediating the changes in
neuronal morphology upon Toxoplasma-induced neuroinflammation.
Flow cytometric analysis revealed the upregulation of p75NTR sur-
face expression by innate immune cells in the periphery and CNS of
wild-type (WT) mice. Although cell recruitment and phagocytic
capacity of p75NTRexonIV knockout (p75−/−) mice were not altered,
the activation status of innate immune cells was modified as indi-
cated by differences in their phenotypic properties. Accordingly,
cytokine production by recruited myeloid cells in brains of T. gondii-
infected p75−/− mice was changed as the anti-inflammatory IL-10
and proinflammatory IL-6 and IL-1α and were upregulated. Applying
Western blot analysis to whole brain lysate we could show a strong
increase of proBDNF protein levels in infected WT and p75−/− ani-
mals. Finally, changes in spine density were rescued in infected
p75−/− mice when compared to WT controls. Taken together, these
findings indicate that proBDNF-mediated signaling via the p75NTR
affects immune cell activation and neuronal morphology in the brain
upon inflammation.
2 | MATERIALS AND METHODS
2.1 | Animals
The experiments were performed using age-matched 2- to 4-month-
old female wild-type (WT), Thy1-eGFP-M transgenic (Feng et al.,
2000) or p75NTRexonIV knockout (p75−/−) C57BL/6 mice. The p75−/−
mice were generated in the laboratory of Prof. Georg Dechant
(University of Innsbruck, Austria) and were genotyped as previously
described (von Schack et al., 2001). C57BL/6 WT were obtained from
Janvier (Cedex, France). Thy1-eGFP-M transgenic mice and p75−/−
mice and littermate controls were obtained from animal facility at the
TU Braunschweig. All animal care was in accordance with institutional
guidelines. Food and water were available ad libitum and experiments
were performed in accordance to National Institutes of Health (NIH)
Guidelines for the Care and Use of Laboratory Animals with local gov-
ernment approval.
194 DÜSEDAU ET AL.
2.2 | Infection
For the infection of mice with T. gondii, cysts of the type II strain
ME49 were first collected from brains of female NMRI mice infected
with T. gondii cysts 10–12 months earlier as described before (Möhle
et al., 2016). Each animal was infected with a dose of 2 cysts intraperi-
toneally while naive control animals were mock infected with sterile
Phosphate buffered saline (PBS). Mice were sacrificed 4 weeks post
infection (p.i.).
2.3 | Tissue preparation and analysis of neuronal
morphology
All mice were transcardially perfused with 4% Paraformaldehyde
(PFA), the brain was postfixed and the hemispheres were sliced at
300 μm (for reconstruction of the dendrites) or 150 μm (for spine
density analysis) with a vibratome (VT 1200S; Leica) and mounted
with an anti-fading mounting medium. To analyze dendritic architec-
ture, hippocampal CA1 neurons were imaged using a 20x (NA 0.8)
objective for acquiring z-stacks (step size 1 μm). Only isolated, not
overlapping eGFP expressing hippocampal CA1 neurons were chosen.
Morphological analysis was performed using Neurolucida®
(Microbrightfield Bioscience) to trace the dendritic tree and perform a
Sholl analysis of dendritic complexity (Sholl, 1953). To analyze den-
dritic spine density, z-stacks of mid-apical dendrites from hippocampal
CA1 and cortical layer V/VI pyramidal neurons were acquired using a
40x oil objective (NA 1.3) with z-steps of 0.5 μm. The number of
spines and the dendritic length was analyzed on three-dimensional
images using ImageJ software using the multipoint tool and the seg-
mented line respectively. The experimenter was blind to the genotype
and treatment throughout all phases of the experiment and analysis.
2.4 | Immunohistochemistry
After fixation by perfusion, as above, the hippocampi were dissected,
postfixed in 4% PFA and subsequently cryoprotected. The hippocampi
were cryo-sectioned at 30 μm and after a blocking and permeabiliza-
tion step the sections were incubated overnight with anti-Iba1 pri-
mary antibodies (dilution of 1:1,000; Synaptic Systems, #234003),
then with a Cy3-conjugated goat anti-rabbit IgG (1:500, Dianova) and
mounted using an anti-fading mounting medium. For analyzing
changes in microglia density z-stacks of 3 to 5 regions of interest
(ROIs) per mouse were imaged using a 20x objective (NA 0.8) at a z-
step of 1 μm. The number of microglia was counted using the multi-
point tool of ImageJ and is expressed as number of cells per mm3 of
tissue. For analyzing the enwrapping of microglia around neuronal cell
bodies, confocal images of at least 10 randomly selected eGFP-
expressing CA1 pyramidal neurons were analyzed with a BX61WI
FluoView 1000 (FV1000) Olympus confocal microscope. Stacks were
acquired using a 40x oil objective (NA 1.3), z-steps of 1 μm. The neu-
ron profile as well as the length of Iba1 positive microglia processes
contacting the neuronal cell body were measured using the freehand
tool from ImageJ for each z-plane and summed to obtain one value of
overlap per each neuron (expressed in % of the neuronal perimeter).
2.5 | Cell isolation
Blood of mice was collected and prepared as described before (Biswas
et al., 2015). Brains were collected from mice previously perfused
intra-cardially with sterile PBS. Obtained samples were homogenized
in a buffer containing HBSS (Gibco), 1M HEPES (pH 7.3, Thermo
Fisher) and 45% glucose before sieving through a 70 μm cell strainer.
The homogenate was fractioned on a discontinuous 30–70% Percoll
gradient (GE Healthcare) and collected cells were washed in PBS and
used subsequently for further experiments. To isolate peripheral
immune cells, spleens of mice were passed through a 40 μm cell
strainer followed by a lysis of erythrocytes in RBC lysis Buffer
(eBioscience). Cells were pelleted and stored in −80 C until
further use.
2.6 | Flow cytometric analysis
For flow cytometric analysis of cell phenotypes, isolated cells were
first incubated with Zombie NIR™ or Zombie Violet™ fixable dye
(Biolegend) for live/dead discrimination and with anti-FcγIII/II recep-
tor antibody (clone 93) to prevent unspecific binding of antibodies.
Cells were further stained with fluorochrome-conjugated antibodies
against cell surface markers in FACS buffer containing 2% fetal bovine
serum and 0.1% sodium azide. CD45 (30-F11), CD11b (M1/70), Ly6C
(HK1.4), MHCII I-A/I-E (M5/114.15.2), CD4 (GK1.5), CD8 (53–6.7),
CD11c (N418), CD80 (16-10A1), and F4/80 (BM8) were all purchased
from eBioscience. Ly6G (1A8), CD3 (17A2), and CD25 (3C7) were
purchased from Biolegend and p75NTR (MLR2) was bought from
Thermo Fisher. Fluorescence Minus One (FMO) controls were used to
determine the level of autofluorescence.
For flow cytometric analysis of intracellular cytokines and pro-
teins, single cell suspensions of brains from infected animals were re-
stimulated with 0.21 μg/μl Toxoplasma lysate antigen in a 96-well
plate (5 × 105 cell/well) for 6 hr. After 2 hr of incubation, Brefeldin A
(10 μg/ml, GolgiPlug, BD Biosciences) and Monensin (10 μg/ml Golgi-
Stop, BD Biosciences) were added. Thereafter, cells were incubated
with ZOMBIE NIR™ or Violet™ fixable dye and anti-FcγIII/II receptor
antibody. Next, surface staining was performed on the cells with anti-
bodies for CD45 (30-F11), CD11b (M1/70), Ly6C (HK1.4), Ly6G
(1A8), CD3 (17A2), CD4 (GK1.5), CD8 (53–6.7), in FACS buffer. Cells
were fixed in 4% paraformaldehyde and then permeabilized using Per-
meabilization Buffer (Biolegend). Intracellular cytokines and proteins
were stained with fluorochrome-conjugated antibodies: IL-1α (ALF-
161), IL-1β (NJTEN3), IL-6 (MP5-20F3), IL-10 (JES5-16E3), IL-12
(C17.8), purchased from eBiosciences); iNOS (BD Biosciences,
610330) in Permeabilization Buffer. Matched isotype controls were
used to assess the level of unspecific binding.
A minimum of 100,000 cells were acquired using the BD FACS
Canto II and Thermo Fisher Attune NxT flow cytometer. Obtained
data were analyzed using FlowJo software (Version 10 Tree Star).
2.7 | Ex vivo phagocytosis assay
Isolated cells from brains of infected mice were transferred into wells
of a 96-well plate (4 × 105 cells/well) and incubated at 37 C for 1 hr.
Negative controls were set up by treatment of cells with cytochalasin D
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(Sigma) for 30 min before FITC-fluorescent, carboxylated latex beads
were added (d = 1 μm, Fluospheres, Thermo Fisher). Next, cells were
washed twice and stained for flow cytometric analysis. Phagocytosis of
beads by each cell population was determined using the BD FACS
Canto II flow cytometer and obtained data were analyzed using FlowJo
software (Version 10 Tree Star).
2.8 | In vitro migration assay
Isolated blood cells were washed in RPMI (Gibco) medium containing
10 mM HEPES (Sigma) and 0.1% bovine serum albumin (pH 7.4)
before being transferred into a Transwell insert (3 × 105cells/well,
Costar Corning) previously coated with recombinant human Fc-tagged
murine VCAM (5 μg/ml, R&D systems) in PBS. The inserts were then
placed on a 24-well plate filled with RPMI medium (10 mM HEPES,
0.1% BSA, pH 7.4), with or without stimulation of mCCL2 (20 ng/ml,
R&D systems). After 2 hr incubation at 37 C and 5% CO2, cells were
isolated from the lower compartment and counted under a light
microscope.
2.9 | Western blot analysis
For Western blot analysis, proteins were either isolated from whole
mouse brains or spleenocytes obtained previously. In the case of
brain samples, collected tissue was immediately snap frozen in liquid
nitrogen and stored in −80 C until further preparation. In all cases,
samples were lysed on ice in RIPA lysis buffer containing protease
inhibitors, 50 mM Tris/HCl (pH 7.4); 150 mM NaCl; 1% IGEPAL CA-
630; 0.25% Na-deoxycholate; 1 mM NaF. Proteins were separated
by SDS-polyacrylamide gel electrophoresis (12.5%) and transferred
to nitrocellulose. Membranes were incubated overnight at 4 C in a
1:500 dilution of anti-BDNF antibody (abcam, #203573) or 1:000
dilution of anti-NFG antibody (abcam, #52918), respectively. As a
loading control the same membrane was incubated with a 1:1,000
dilution of anti-β-Tubulin-III antibody (Sigma, #T8660) or, for
immune cells derived from spleens, with GAPDH 1:1,000 (Cell sig-
naling, #2118S). Bound antibodies were revealed using enhanced
chemiluminescence assay and densitometric analysis of blots was
performed using ImageJ with Fiji distribution (Schindelin
et al., 2012).
2.10 | Statistics
Data from flow cytometry, RT-PCR and Western blot analysis were
analyzed by Mann–Whitney test for two groups or one-way and two-
way ANOVA for several groups followed by Tukey's post hoc HSD test
with GraphPad Prism 6 (San Diego, CA). The Sholl analysis data were
analyzed applying a two-tailed Student's t test point by point. Total
complexity and spine density were compared between groups using a
one-way ANOVA followed by a post hoc Tukey's HSD test. In all cases,
results were presented as mean  standard error of the mean (SEM)
and were considered significant, with p < .05.
3 | RESULTS
3.1 | Infection with T. gondii upregulates p75NTR on
innate immune cells in the brain
The first aim of this study was to investigate the level of p75NTR sur-
face expression on innate immune cells in steady state and upon
inflammation. Therefore, we analyzed isolated cells from the blood
and brain of naive and T. gondii-infected C57BL/6 WT mice by flow
cytometry. In the blood of noninfected mice, we already observed a
large number of Ly6Chi monocytes (71.5  6.5%) and Ly6Clow macro-
phages (73.1  0.6%) expressing p75NTR whereas Ly6Cint blood
monocytes expressed the neurotrophin receptor to a lesser extent
(39.4  2.0%; Figure 1c). Upon infection, the cellular expression of
p75NTR by mononuclear cells in the blood was increased on all subsets
(Ly6Chi monocytes: 71.5  6.5% vs. 83.7  0.7%; p < .14 / Ly6Cint
blood monocytes: 39.4  2.0% vs. 51.6  3.4%; p < .07 / Ly6Clow
macrophages: 73.1  0.6% vs. 83.1  1.6%; p < .04). Next, we ana-
lyzed immune cells isolated from the brains of noninfected and
T. gondii-infected WT mice (Figure 1d, d’). Considering the low number
of recruited myeloid cells with approximately 1% of living single cells
in the CNS under steady state condition (data not shown) the corre-
sponding flow cytometric histograms are not representative
(Figure 1d). In control brains a small proportion of microglia cells
expressed p75NTR (21.4  1.3%). Upon infection, the amount of
microglia and recruited myeloid cells expressing p75NTR increased
(microglia: 21.4  1.3% vs. 94.2  1.2%; p < .04 / myeloid cells:
37.3  5.3% vs. 85.0  1.3%; p < .04). Among the myeloid cell sub-
sets, Ly6Chi monocytes and Ly6Cint brain DCs displayed similar sur-
face expression of the neurotrophin receptor (Ly6Chi monocytes:
20.3  12.8% vs. 86.8  1.2%; p < .04 / Ly6Cint brain DCs:
47.9  11.4% vs. 87.1  1.0%; p < .04) and the subset of Ly6Clow
macrophages increased their p75NTR surface expression the greatest
(47.4  2.8% vs. 94.7  1.3%; p < .04) but the receptor was not
detected on recruited lymphocytes (1.8  0.6% vs. 6.2  0.8%;
p < .04). When comparing the median fluorescence intensity (MFI) of
the p75NTR expression level between microglia and recruited myeloid
cells in the CNS we could show that expression of p75NTR was similar
between peripheral innate immune cells and brain resident immune
cells (Figure 1e). Taken together, our results indicate the upregulation
of p75NTR by innate immune cells in the blood and CNS upon T. gondii
infection.
3.2 | Knockout of p75NTR does not affect cell
recruitment during T. gondii infection
To elucidate the effect of p75NTR on the behavior of immune cells we
utilized p75NTRexonIV knockout (p75−/−) mice. Due to the strong
expression of the neurotrophin receptor on peripheral blood mononu-
clear cells we first aimed to analyze the potential effect of p75NTR on
immune cell trafficking. Thus, we infected p75−/− and WT mice with
T. gondii and analyzed the composition of immune cells in the hippo-
campus and cortex by flow cytometry (Figure 2a–c). When compared
to WT animals, no difference was observed in the composition of
brain resident microglia cells in cortex (WT: 22.5  2.3% vs. p75−/−:
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FIGURE 1 Flow cytometric analysis of p75NTR surface expression on immune cells upon infection with T. gondii. Cells were isolated from blood
and brains of noninfected and T. gondii-infected mice then analyzed by flow cytometry. (a, a0) Representative gating strategy for myeloid cells
from blood of animals infected with T. gondii. Cells were selected based on the forward-scatter/side-scatter plot (FSC/SSC), dead cells were
excluded and only single cells were selected for further analysis (not shown). (a) Neutrophil granulocytes (CD11b+Ly6G+) in the blood were
excluded (upper gate) and monocytes remained as CD11b+Ly6G− cells (lower gate). (a’) Monocytes were further divided with respect to the
surface expression of Ly6C into CD11b+Ly6Chi inflammatory monocytes (upper gate), CD11b+Ly6Cint blood monocytes (middle gate) and
CD11b+Ly6Clow resident macrophages (bottom gate). (b, b0) Representative gating strategy for immune cells isolated from the brain of animals
infected with T. gondii. After FSC/SSC gating, dead cells were excluded and only single cells were selected for further analysis (not shown).
(b) Based on the expression of CD45 and CD11b, CD45+CD11blo lymphocytes (upper left gate), CD45+CD11bhi myeloid cells (upper right gate)
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20.8  1.9%; p < .98) or hippocampus (WT: 32.5  4.4% vs. p75−/−:
32.0  2.8%; p < .99) of p75−/− mice. Further, the knockout of
p75NTR did not result in an altered recruitment of myeloid cells from
the periphery to the cortex (WT: 13.7  0.8% vs. p75−/−:
10.7  1.0%; p < .59) or hippocampus (WT: 17.8  1.5% vs. p75−/−:
14.8  2.7%; p < .6) of infected mice. In accordance to these findings,
no differences were found in the composition of lymphocytes in cor-
tex (WT: 34.8  3.6% vs. p75−/−: 39.3  2.0%; p < .66) or hippocam-
pus (WT: 37.3  3.5% vs. p75−/−: 44.0  0.8%; p < .34). Next, we
addressed whether p75NTR knockout affects the migratory response
of immune cells. Therefore, an in vitro migration assay was employed
with isolated leukocytes from WT and p75−/− mice and compared the
total number of migrated cells with or without stimulation by the che-
mokine CCL2 (Figure 2d). In unstimulated samples, no differences in
the migration of immune cells from WT (0.22 × 104 cells/ml  0.037
× 104 cells/ml) or p75−/− mice (0.23 × 104 cells/ml  0.018 × 104
cells/ml; p < .99) were detected. Upon administration of CCL2, the
total number of migrated cells strongly increased for both groups,
however, no alterations were observed between WT (0.72 × 104
cells/ml  0.034 × 104 cells/ml) and knockout animals (0.72 × 104
cells/ml  0.021 × 104 cells/ml; p < .99). In summary, knockout of
the p75NTR did not have an impact on the recruitment of immune cells
to the CNS and did not lead to differences in the migratory response
of leukocytes.
3.3 | Phenotypic characterization of innate immune
cells in the CNS of p75−/− mice upon T. gondii-induced
neuroinflammation
Although no change was detected in the composition of immune cells
in the brains of p75−/− mice, we characterized phenotype and activa-
tion status of the cell subsets upon T. gondii-induced neuroinflamma-
tion. Flow cytometric analysis was performed to assess the expression
level of distinct surface markers by immune cell subsets isolated from
infected brains of WT and p75−/− mice. When compared to WT, brain
resident microglia from p75−/− animals showed a significantly reduced
MFI for Major Histocompatibility complex (MHC) class II surface
expression (p < .02), CD11c (p < .01) and co-stimulatory CD80
(p < .03), as indicated in Figure 3a–d. The histograms show that the
subsets expressing the indicated markers were similar between the
experimental groups for MHC class II (WT: 95.8  0.5% vs. p75−/−:
98.6  0.5%; p < .09) and CD11c (WT: 89.9  2.9% vs. p75−/−:
91.4  1.1%; p < .86). Yet CD80 was found to be expressed by fewer
cells in p75−/− samples (WT: 94.5  0.4% vs. p75−/−: 88.6  1.2%;
p < .02; Figure 3a’–d’). In contrast to microglia, Ly6Chi monocytes
showed no differences between p75−/− and WT animals with respect
to MFI values or expressing cell fractions for the surface markers
MHC II, CD11c, F4/80, and CD80 (Figure 3e–h’). As we reported pre-
viously, peripheral Ly6Chi inflammatory monocytes enter the paren-
chyma and differentiate into Ly6Cint brain dendritic cells (DCs) and
FIGURE 2 Immune cell recruitment to cortex and hippocampus of WT and p75−/− mice upon infection with T. gondii and in vitro leukocytes
migration (a–c) the composition of immune cells isolated from cortices and hippocampi of T. gondii-infected WT and p75−/− mice was determined
by flow cytometric analysis. Cell populations were gated as described in Figure 1b,b0 and bar charts display the fraction of each population as
frequency of living single cells (SEM). (d) The migratory response of leukocytes from T. gondii-infected WT and p75−/− mice was assessed
in vitro by a transwell migration assay. Isolated cells were either stimulated with the chemokine CCL2 or were left unstimulated. Bar charts
represent the mean of total cell count (SEM) in the compartment below the membrane. Differences between groups were analyzed by two-way
ANOVA with post hoc Tukey's HSD test
and CD45intCD11bint microglia (lower right gate) were identified. Next, neutrophil granulocytes were excluded from the myeloid cell population
by their expression of CD11b and Ly6G (not shown). (b0) Myeloid cells were further divided into CD11b+Ly6Chi inflammatory monocytes (upper
gate), CD11b+Ly6Cint monocyte-derived DCs (middle gate) and CD11b+Ly6Clow monocyte-derived macrophages (bottom gate; Biswas et al.,
2015). The lymphocyte population was subdivided into CD3+CD4+ T cells and CD3+CD8+ T cells (data not shown). Surface expression of p75NTR
was analyzed on blood cells (c) and brain cells (d) of noninfected mice and on blood cells (c0) and brain cells (d’) of animals infected with T. gondii.
Cell populations were selected as described above and histograms show the representative expression level of p75NTR by the cell population in
comparison to the corresponding FMO control. Bars mark cells positively expressing p75NTR and numbers above bars represent the percentage of
cells (SEM) in the respective population. (e) Flow cytometric analysis of p75NTR surface expression on cells isolated from brains of naive and
T. gondii-infected mice. Cell populations were selected as described above and bar charts display the median fluorescence intensity (MFI; SEM).
Differences between groups were analyzed by one-way ANOVA with post hoc Tukey's HSD test (*p < .05; ***p < .001; ****p < .0001)
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Ly6Clow macrophages (Biswas et al., 2015). Interestingly, Ly6Cint brain
DCs in p75−/− animals displayed a significant reduction in the MFI of
CD11c (p < .002) although the fraction of expressing cells was not
changed (WT: 83.9  0.1% vs. p75−/−: 78.0  1.4%; p < .1;
Figure 4c). In accordance to this, knockout of p75NTR also resulted in
a diminished MFI for CD11c (p < .03) and F4/80 (p < .001) surface
expression levels on Ly6Clow macrophages (Figure 4e–h’) but not in
cells positively expressing the respective surface receptors (CD11c:
FIGURE 3 Phenotypic analysis of activated microglia and Ly6Chi monocytes from brains of T. gondii-infected WT and p75−/− mice. The surface
expression of activation markers on cells isolated from infected brains of WT and p75−/− mice was determined by flow cytometric analysis. Cell
populations were selected as described in Figure 1b, b0. (a–h) Histograms show the representative expression level of the surface marker by cells
(WT mice tinted, p75−/− mice without tint) in comparison to the corresponding FMO control and bars mark cells positively expressing the surface
marker. Numbers above bars represent the percentage of cells (SEM) in the respective population. (a0–h0) Bar charts display the MFI (SEM) for
the specific surface marker. Differences between groups were analyzed by Mann–Whitney test (*p < .05, ** p < .01)
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WT: 97.5  0.3% vs. p75−/−: 92.7  1.0%; p < .1 / F4/80: WT:
97.9  0.4% vs. p75−/−: 86.6  0.7%; p < .24). We further investi-
gated the CD4+ and CD8+ T cell lymphocyte populations and quanti-
fied their activation status in infected brains of WT and p75−/−
animals by flow cytometric analysis (Supporting Information 1A–C0).
The frequencies of CD4+ T cells (WT: 50.8  1.2% vs. p75−/−:
52.0  2.3%; p < .74) and CD8+ T cells (WT: 46.4  1.3% vs. p75−/−:
45.1  2.2%; p < .86) in T. gondii-infected brains were not differing
FIGURE 4 Phenotypic analysis of activated Ly6Cint brain DCs and Ly6Clow macrophages from brains of T. gondii-infected WT and p75−/− mice.
The surface expression of activation markers on cells isolated from infected brains of WT and p75−/− mice was determined by flow cytometric
analysis. Cell populations were selected as described in Figure 1b, b0. (a–h) Histograms show the representative expression level of the surface
marker by cells (WT mice tinted, p75−/− mice without tint) in comparison to the corresponding FMO control and bars mark cells positively
expressing the surface marker. Numbers above bars represent the percentage of cells (SEM) in the respective population. (a0–h0) Bar charts
display the MFI (SEM) for the specific surface marker. Differences between groups were analyzed by Mann–Whitney test (* p < .05, ** p < .01,
*** p < .001)
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between p75−/− and WT mice. Interestingly, significantly less CD4+
T cells in p75−/− mice were expressing the IL-2 receptor alpha chain
CD25 (WT: 13.6  0.2% vs. p75−/−: 11.4  0.1%; p < .03) which also
resulted in a significantly lower MFI (p < .03). CD8+ T cells of both
experimental groups expressed CD25 equally (WT: 12.2  1.2%
vs. p75−/−: 9.9  0.8%; p < .34) and did not show significant differ-
ences in MFI. In conclusion, the phenotypic analysis of brain resident
and recruited peripheral immune cells during cerebral toxoplasmosis
revealed several differences between p75−/− and WT animals imply-
ing a modified activation of the immune cells in knockout animals.
3.4 | Knockout of p75NTR has no effect on
phagocytic capacity but alters intracellular cytokine
production by innate immune cells
To further examine whether the function of immune cells in p75−/−
mice could also be affected, an ex vivo phagocytosis assay was per-
formed. For that reason, resident, and recruited immune cells from
infected brains were isolated and subsequently incubated with FITC-
fluorescent latex beads. The MFI of each population in the FITC
detection channel was determined by flow cytometry and results
were compared between WT and p75−/− mice (Figure 5a). The results
reveal, that phagocytic activity of microglia or recruited myeloid cell
populations in p75−/− mice and WT cells was not distinct.
Next, the morphological activation of microglia was assessed by
analyzing their structural alterations and density. Under steady state
conditions, in both WT and p75−/− mice the microglia in the CA1
region of the hippocampus showed the ramified morphology, typical
for resting cells (Figure 5b above). Upon T. gondii infection, microglia
transformed their morphology to an activated amoeboid form with
hypertrophic processes that tightly wrap around the cell bodies and
main dendrites of eGFP-positive CA1 pyramidal neurons (Figure 5b
below and 5b’). We further quantified the overlay between Iba1+
microglial processes and the perimeter of eGFP expressing pyramidal
neurons and observed a significant increase upon T. gondii infection
(Figure 5c; WT: p < .001; p75−/−: p < .001). The increase in microglia/
neuron overlap was not significantly different in p75−/− when com-
pared to WT infected mice (Figure 5c). Finally, microglia density was
quantified and showed an equally significant increase in the number
of Iba1+ microglia cells in the CA1 region of p75−/− and WT infected
mice (Figure 5d; WT p < .001; p75−/− p < .001). Taken together, the
results show a strong activation of microglia upon T. gondii infection
that does not significantly differ between WT and p75−/− mice.
In the next step, we focused on the flow cytometric analysis of
cytokine expression by immune cell populations in brains of T. gondii-
infected animals. Upon in vitro re-stimulation with Toxoplasma lysate
antigen (TLA) the production of IL-1α, IL-6, and IL-10 by microglia
from WT and p75−/− mice did not differ (Figure 6a–d’). Interestingly, a
significantly higher percentage of Ly6Chi monocytes from p75−/− ani-
mals expressed IL-1α when compared to WT samples (WT:
32.1  1.8% vs. p75−/−: 48.7  3.1%; p < .0001) despite MFI values
being similar (p < .2; Figure 6e, e’). Moreover, p75NTR knockout
resulted in an increased MFI of IL-10 (p < .03) but not in a higher
number of Ly6Chi monocytes expressing this cytokine (WT:
0.5  0.2% vs. p75−/−: 1.2  0.2%; p < .99; Figure 6h, h’). Similarly,
analysis of Ly6Cint brain DCs reported significantly higher fluores-
cence intensities for IL-10 (p < .03) and also IL-6 (p < .03) in infected
p75−/− animals while the frequency of secreting cells did not differ
(Figure 7a–d’). We also discovered an increased percentage of Ly6Clow
macrophages from p75−/− mice secreting IL-1α (WT: 26.3  1.7%
vs. p75−/−: 38.6  3.2%, p < .0004), resulting in significantly higher
median fluorescence (p < .03). In addition, significantly elevated MFIs
were also detected for IL-6 (p < .03) and IL-10 (p < .3) when com-
pared to WT samples while positively expressing cell fractions were
not altered (Figure 7e–h’). Levels of IL-12 and inducible nitric oxide
synthase (iNOS) in microglia and recruited mononuclear cells were
analyzed upon T. gondii infection (Supporting Information 2A-H0).
Here no differences were observed in MFI values or cells positively
producing these proteins. To address the question whether the
altered cytokine milieu in infected brains of p75−/− mice would affect
the survival of cells, we performed an apoptosis assay via flow cyto-
metry (Supporting Information 3A, B). While the frequencies of living
cells and apoptotic cells did not differ between WT and p75−/− ani-
mals, necrotic cells were significantly reduced in KO mice (p < .03).
In summary, we found that knockout of p75NTR leads to a higher
secretion of proinflammatory mediators and anti-inflammatory IL-10
by myeloid cell populations but had no effect on brain resident
microglia.
3.5 | Chronic infection with T. gondii increases
proBDNF levels in WT and p75−/− mice
Previously, we reported that infection with T. gondii induces changes
in the morphology of noninfected neurons and also leads to modified
brain connectivity in rodents (Parlog et al., 2014) possibly explaining
the behavioral changes observed in infected rats (Berdoy, Webster, &
Macdonald, 2000). With regards to this, related studies have reported
a link between changes in neurotrophin levels and the progression of
neurodegenerative diseases such as schizophrenia and Alzheimer's
disease (Capsoni, Brandi, Arisi, D'Onofrio, & Cattaneo, 2011; Green,
Matheson, Shepherd, Weickert, & Carr, 2011). To obtain more infor-
mation about possible changes in neurotrophin expression levels
within the CNS of WT and p75−/− mice upon the infection with
T. gondii we performed Western blot analysis. Isolated proteins from
brain lysate of noninfected and infected WT and p75−/− mice were
analyzed for NGF, BDNF, and proBDNF levels (Figure 8a–d). Neither
infection with T. gondii nor knockout of p75NTR was found to have an
effect on NGF or BDNF levels which remained at baseline (NGF: WT
control vs. WT inf.: p < .99; p75−/− control vs. p75−/− inf.: p < .74 /
BDNF: WT control vs. WT inf.: p < .75; p75−/− control vs. p75−/− inf.:
p < .99; Figure 8b, c). Remarkably, proBDNF which was detectable in
small quantities in control WT and p75−/− mice increased strongly
upon T. gondii infection (WT control vs. WT inf.: p < .0001; p75−/−
control vs. p75−/− inf.: p < .0001; Figure 8d). Assuming that this
observed upregulation of proBDNF was possibly facilitated by the
recruited immune cell populations due to T. gondii infection, we set
out to confirm our hypothesis. To this end, peripheral immune cells
were isolated from spleens of control and infected WT mice and
proBDNF expression was analyzed by Western blot (Figure 8e, f).
While protein levels of the proneurotrophin were detectable at lower
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FIGURE 5 Ex vivo phagocytosis assay of immune cells isolated from brains of WT and p75−/− mice infected with T. gondii. (a) The phagocytic
capability of immune cells isolated from T. gondii-infected brains of WT and p75−/− mice was assessed ex vivo by a phagocytosis assay. Isolated
cells were incubated together with FITC-fluorescent latex beads and analyzed by flow cytometry. Cell populations were selected as described
above and Bar charts display the MFI (SEM) in the FITC detection channel. Differences between groups were analyzed by Mann–Whitney test.
(b) The images above show a typical resting Iba1+ microglia (red) under control conditions for hippocampal CA1 region of WT (left) and p75−/−
mice (right). Below are typical images of activated Iba1+ microglia (red) upon chronic T. gondii infection for hippocampal CA1 region of WT (left)
and p75−/− mice (right). In green are eGFP-labeled CA1 pyramidal neurons. Scale bars are 50 μm. (b0) The images show a higher magnification
(scale bar is 10 μm) of eGFP+ CA1 pyramidal cell bodies and Iba1+ microglia processes under control conditions (above) and chronic T. gondii
infection (below) for WT (left) and p75−/− mice (right). (c) Bar charts show the quantification for the overlay (in %) between Iba1+ microglia
processes and eGFP expressing cell bodies for WT and p75−/− mice under control conditions and upon chronic T. gondii infection. (d) Bar charts
show the quantification for Iba1+ microglia density for WT and p75−/− mice under control conditions and chronic T. gondii infection. Differences
between groups were analyzed by Student's T-test. All values are shown as mean  SEM (*** p < .001)
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FIGURE 6 Flow cytometric analysis of intracellular cytokines in microglia and Ly6Chi monocytes from brains of T. gondii-infected WT and p75−/−
mice. Isolated cells from brains of T. gondii-infected WT and p75−/− mice were re-stimulated with Toxoplasma lysate antigen in vitro and
intracellular proteins were stained for flow cytometric analysis. Cell populations were selected as described above. (a–h) Histograms show the
representative intracellular expression level of the molecules by cells (WT mice tinted, p75−/− mice without tint) in comparison to the
corresponding isotype control. Bars mark cells positive for the particular protein and numbers above bars show the percentage of cells (SEM) in
the respective population. (a0–h0) Bar charts display the MFI (SEM) for the respective fluorochrome-conjugated antibody for the particular
protein. Differences between groups were analyzed by Mann–Whitney test (*p < .05)
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FIGURE 7 Flow cytometric analysis of intracellular cytokines in Ly6Cint brain DCs and Ly6Clow macrophages from brains of T. gondii-infected WT
and p75−/− mice. Isolated cells from brains of T. gondii-infected WT and p75−/− mice were re-stimulated with Toxoplasma lysate antigen in vitro
and intracellular proteins were stained for flow cytometric analysis. Cell populations were selected as described above. (a–h) Histograms show the
representative intracellular expression level of the molecules by cells (WT mice tinted, p75−/− mice without tint) in comparison to the
corresponding isotype control. Bars mark cells positive for the particular protein and numbers above bars show the percentage of cells (SEM) in
the respective population. (a0–h0) Bar charts display the MFI (SEM) for the respective fluorochrome-conjugated antibody for the particular
protein. Differences between groups were analyzed by Mann–Whitney test (*p < .05)
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quantities in control mice, T. gondii infection significantly increased
the levels of proBDNF (WT control vs. WT inf.: p < .03) supporting
our previous findings in brain homogenate. Taken together we could
show that protein levels of NGF and BDNF were neither affected by
p75NTR KO nor by T. gondii infection. In contrast, proBDNF levels
were found highly increased in the brain and periphery of
infected mice.
3.6 | Role of p75NTR in mediating the effect of a
chronic T. gondii infection on dendritic architecture
Chronic infection with T. gondii was shown to result in a significant
reduction in neuronal morphology and connectivity both in the cortex
and hippocampus of C57BL/6 mice (Parlog et al., 2014). Interestingly,
the p75NTR was reported to specifically mediate negative structural
changes at pyramidal neurons (Zagrebelsky et al., 2005) and its
expression levels are modulated upon neuroinflammation (Meeker &
Williams, 2014). Thus, we addressed whether knocking out p75NTR
might rescue neuronal morphology upon T. gondii infection. While at a
qualitative level dendritic complexity of CA1 pyramidal neurons is
clearly reduced in WT mice upon chronic T. gondii infection
(Figure 9a), no obvious differences in dendritic architecture can be
observed in infected p75−/− mice (Figure 9a’). Further, Sholl analysis
was applied to quantify dendritic complexity relative to the distance
from the cell body. When comparing control (open circles) and
infected WT mice (black circles) a significantly lower dendritic com-
plexity along the entire length of both the apical (Figure 9b; F
(1,38) = 4.677 p < .05) but not the basal (Figure 9c) dendritic trees
was detected upon T. gondii infection. When p75−/− mice were ana-
lyzed no significant difference in dendritic complexity could be
observed along the entire length of the apical dendrite (Figure 9b’)
upon T. gondii infection (black circles) compared to noninfected
p75−/− mice (open circles). On the contrary, dendritic complexity for
the basal dendrites of CA1 pyramidal neurons of p75−/− mice was sig-
nificantly lower in the proximal part (Figure 9c’; F(1. 52) = 4.283
p < .05) during infection (black circles). The analysis of total dendritic
complexity confirmed the observations above and showed a slight
decrease in WT mice upon T. gondii infection for the apical but not for
the basal dendrites (Figure 9b”, c00; Table 1). Interestingly, total den-
dritic complexity was not significantly decreased for both apical and
basal dendrites of infected p75−/− mice when compared to controls
(Figure 9b”, c00; Table 1). Taken together these results confirm previ-
ous findings showing a significant loss in neuronal complexity in WT
mice upon T. gondii infection and indicate that deletion of p75NTR pre-
vents the T. gondii-induced changes in dendritic architecture of CA1
pyramidal neurons. Next, we compared dendritic spine density
changes in WT and p75−/− cortical and hippocampal pyramidal neu-
rons upon T. gondii infection. Both for CA1 and for Layer V/VI pyrami-
dal neurons, dendritic spine density was significantly reduced during
infection in WT mice (Figure 9d–e’; CA1 apical dendrites p < .05; CA1
basal p < .01; LV/VI apical p < .01; LV/VI basal p < .001). In p75−/−
mice, dendritic spine density upon T. gondii infection was only slightly,
but not significantly lower than in noninfected mice for both compart-
ments of CA1 pyramidal neurons and for the basal dendrites of Layer
V/VI pyramidal neurons (Figure 9d–e’; Table 1). The only exceptions
were the LV/VI apical dendrites showing a significantly lower spine
FIGURE 8 Western blot analysis of neurotrophins protein levels in brains of T. gondii-infected WT and p75−/− mice and from isolated immune
cells. (a–d) Western blot analysis of NGF, BDNF and proBDNF in whole-brain lysate from control and infected mice, alongside β-Tubulin-III
loading controls. Bar charts indicate densitometric analysis of blots, expressed as mean (SEM). Differences between groups were analyzed using
a one-way ANOVA with post-hoc Tukey's HSD test. (e, f) Western blot analysis of proBDNF in isolated immune cells from control and T. gondii-
infected WT mice with GAPDH loading controls. Bar charts indicate densitometric analysis of blots, expressed as mean (SEM). Differences
between groups were analyzed by Mann-Whitney test. (* p < 0.05, * * * * p < 0.0001)
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density than controls upon infection (Figure 9e; p < .05). For the CA1
basal dendrites dendritic spine density was significantly higher for
infected p75−/− mice versus infected WT mice (Figure 9d'; Table 1;
CA1 basal p < .05). Thus, deletion of p75NTR results in a complete res-
cue of the decrease in dendritic spine density induced by T. gondii
infection for the CA1 pyramidal neurons and a partial one for Layer
V/VI pyramidal neurons.
4 | DISCUSSION
We recently detected significant alterations in dendritic complexity
and dendritic spine density in CNS principal neurons upon cerebral
toxoplasmosis (Parlog et al., 2014). In addition, Western blot analysis
revealed decreased levels of the presynaptic protein Synatophysin
and the postsynaptic protein PSD-95 indicating a significant modifica-
tion of brain connectivity upon T. gondii infection (Parlog et al., 2014).
Moreover, our results indicate distinct modifications in the synaptic
protein composition (Lang et al., 2018). We previously reported that
the chronic infection causes activation of resident microglia and
recruitment of mononuclear immune cell subsets to the CNS (Biswas
et al., 2015, 2017; Möhle et al., 2016). Thus, we hypothesized that
activated immune cells possibly interact with neurons upon infection
and modify their morphology and function. However, the molecular
and cellular mechanisms mediating such interaction remained unex-
plored (Parlog et al., 2015). Neurotrophin signaling has been shown to
modulate the immune system activity at different levels (Minnone, de
Benedetti, & Bracci-Laudiero, 2017; Vega et al., 2003). Therefore, we
investigated the role of p75NTR signaling in modulating neuronal archi-
tecture and immune cell function in the CNS. We showed that p75NTR
influences immune cell activation, function, and cytokine production
possibly contributing to the rescue of neuronal structure. Moreover,
we revealed that infection-induced decrease in dendritic complexity
observed upon T. gondii infection could be rescued by p75NTR
knockout.
In addition to neurons, the expression of p75NTR was also
detected on a variety of immune cells such as B cells and peripheral
mononuclear blood cells (Morgan, Thorpe, Marchetti, & Perez-Polo,
1989). Based on those previous observations, we aimed at investigat-
ing whether p75NTR expression is altered on peripheral blood mono-
nuclear cell subsets during T. gondii infection. Our results already
showed a prominent expression of p75NTR on mononuclear cells in
the blood of control mice under steady state conditions. Infection
with T. gondii led to an increased receptor expression that was found
on Ly6Chi inflammatory monocytes and Ly6Clow resident macro-
phages. These results are in line with results by Choi and Friedman
(2009) who reported an increase of p75NTR expression in astrocytes
and neurons as a response to high levels of IL-1β and TNF. Notewor-
thy, these cytokines have also been shown to be important mediators
in the course of T. gondii infection (Chang, Grau, & Pechère, 1990;
Dimier & Bout, 1993; Schlüter et al., 1999; Yap, Scharton-Kersten,
Charest, & Sher, 1998).
Next, we examined p75NTR expression by resident and recruited
immune cells in the CNS upon infection-induced neuroinflammation.
While lymphocytes did not express this receptor, resident microglia
cells and myeloid-derived mononuclear cell subsets upregulated
p75NTR. Importantly, Ly6Clow macrophages revealed the most
FIGURE 9 Role of p75NTR in mediating the effect of a T. gondii infection on dendritic architecture. (a, a0) Typical camera lucida reconstructions
for the apical and basal dendrites of WT and p75−/− CA1 pyramidal neurons under control conditions and of infected mice with T. gondii. Scale
bars are 100 μm. (b, b0) The graphs show the Sholl analysis for the apical dendrites of CA1 hippocampal pyramidal neurons of WT and p75−/−
CA1 pyramidal neurons under control conditions (open circles) and upon T. gondii infection (black circles). (b00) The graph shows total dendritic
complexity for the apical dendrites of CA1 hippocampal pyramidal neurons of WT and p75−/− CA1 pyramidal neurons under control conditions
and upon T. gondii infection. (c, c0) The graphs show the Sholl analysis for the basal dendrites of CA1 hippocampal pyramidal neurons of WT and
p75−/− CA1 pyramidal neurons under control conditions (open circles) and upon T. gondii infection (black circles). (c00) The graph shows total
dendritic complexity for the basal dendrites of CA1 hippocampal pyramidal neurons of WT and p75−/− CA1 pyramidal neurons under control
conditions and upon T. gondii infection. (d, d0) The graphs show dendritic spine density for the apical and basal dendrites of WT and p75−/− CA1
pyramidal neurons under control conditions and upon T. gondii infection. (e, e0) The graphs show dendritic spine density for the apical and basal
dendrites of WT and p75−/− layer V/VI pyramidal neurons under control conditions and upon T. gondii infection. Total complexity and spine
density were compared between groups using a one-way ANOVA with post hoc Tukey's HSD test. All values are shown as mean  SEM (* p < .05;
**p < .01; *** p < .001)
TABLE 1 Statistical values for total dendritic spine density in
different brain areas and different neuronal subregions
Values for total dendritic complexity (Figure 9b00,c00; apical)
Mice Control T. gondii infection
WT 31; 157.7  6.21 9; 132.1  4.20
p75−/− 38; 146.1  4.07 15; 153.3  7.79
Values for total dendritic complexity (Figure 9b00,c00; basal)
Mice Control T. gondii infection
WT 29; 136.8  5.06 7; 142.3  11.70
p75−/− 41; 156.9  3.86 13; 138.5  10.13
Values for total dendritic spine density apical CA1 (Figure 9d)
Mice Control T. gondii infection
WT 14; 2.23  0.05 3; 1.90  0.07
p75−/− 5; 2.32  0.09 4; 2.15  0.05
Values for total dendritic spine density basal CA1 (Figure 9d’)
Mice Control T. gondii infection
WT 12; 2.09  0.04 3; 1.79  0.05
p75−/− 5; 2.28  0.06 4; 2.07  0.06
Values for total dendritic spine density apical L V/VI (Figure 9e)
Mice Control T. gondii infection
WT 14; 1.36  0.05 3; 0.88  0.02
p75−/− 5; 1.60  0.03 4; 1.19  0.08
Values for total dendritic spine density basal L V/VI (Figure 9e’)
Mice Control T. gondii infection
WT 13;1.34  0.05 3; 0.82  0.01
p75−/− 5; 1.34  0.06 4; 1.10  0.07
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prominent upregulation of p75NTR suggesting a potential effect on
their function.
Previously we have described the crucial involvement of recruited
peripheral myeloid cells in host defense against T. gondii infection
(Dunay et al., 2008). In the murine model of cerebral toxoplasmosis
we found that Ly6Chi inflammatory monocytes were recruited from
the blood to the brain in a CCL2-dependent manner to exert
anti-parasitic activities (Biswas et al., 2015). First, recruited Ly6Chi
inflammatory monocytes produced proinflammatory mediators such
as IL-1α, IL-6, and inducible nitric oxide synthase (iNOS) but were also
able to secrete regulatory IL-10. Second, Ly6Chi inflammatory mono-
cytes further differentiated into Ly6Cint brain DCs and Ly6Clow macro-
phages upon arrival in the CNS and, thus, contributed to antigen
presentation and to parasite control.
Due to the high p75NTR expression on Ly6Chi inflammatory
monocytes in the blood, we investigated whether knockout of p75NTR
would affect the recruitment of monocytes to the CNS upon T. gondii
infection. Previous in vitro studies have reported beneficial effects of
NGF-associated neurotrophin signaling on macrophage chemotaxis
(Kobayashi & Mizisin, 2001; Samah et al., 2008) but in contrast, animal
models of experimental autoimmune encephalomyelitis demonstrated
a reduced CNS infiltration of blood monocytes caused by NGF over-
expression (Flügel et al., 2001). Here, we did not detect significant dif-
ferences in the frequencies of myeloid cells in cortex or hippocampus
of p75−/− mice. Furthermore, the in vitro migratory response of leuko-
cytes towards CCL2 stimulation was not changed. The observed dif-
ferences can possibly be explained by the difference in the model of
neuroinflammation and by the circumstance that NGF protein levels
were not affected by KO of p75NTR. Recent findings by Lee
et al. (2016) reported reduction in CNS trafficking of inflammatory
monocytes after applying a p75NTR blocking antagonist. However, this
study only tested the effects of the p75NTR antagonist on other mem-
bers of the TNF receptor family with cysteine-rich domains. Thus,
they did not exclude interactions of this antagonist with other extra-
cellular receptors which may be an explanation for the altered cell
recruitment and activation (Delbary-Gossart et al., 2016).
Early studies revealed that neurotrophin signaling affects several
functions of immune cells such as inhibition of MHC class II expres-
sion, phagocytosis and proliferation (Elkabes, DiCicco-Bloom, & Black,
1996; Neumann, Misgeld, Matsumuro, & Wekerle, 1998). As the
immune cell activation status reflects their functional properties, we
characterized the phenotype of immune cells in the brains of p75−/−
mice upon Toxoplasma-induced neuroinflammation. Here, we found
that brain resident microglia and subsets of recruited peripheral mye-
loid cells in knockout mice displayed lower levels of MHC class II,
CD11c, F4/80, and CD80 surface receptors implying an altered acti-
vation and function. Therefore, we analyzed the phagocytic capacity
of these immune cells but did not find differences when compared to
WT animals. Besides phagocytosis, the production of inflammatory
mediators is another functional aspect of the cellular immune
response toward inflammation. Accordingly, we analyzed cytokine
production by microglia and recruited peripheral mononuclear cell
subsets. Although p75NTR knockout did not affect microglia cells,
myeloid cell subsets secreted increased amounts of proinflammatory
IL-1α, IL-6, and regulatory IL-10. So far, few studies have reported
about the effects of neurotrophins on the release of immunological
mediators by immune cells and even less is known about the role of
the p75NTR in this context. (Barouch et al., 2001) observed the secre-
tion of nitric oxide by macrophages in an NGF-dependent activation
of mitogen-activated protein kinases. In our experiments, we did not
find alterations in the production of iNOS suggesting that the
reported nitric oxide release could be rather a result of TrkA- instead
of p75NTR-mediated signal transduction (Frossard, Freund, & Adven-
ier, 2004; Stephens et al., 1994; Xie, Tisi, Yeo, & Longo, 2000).
The proinflammatory cytokine IL-1 was shown in many studies to
be involved in memory processes, specifically those related to hippo-
campal functioning (Goshen & Yirmiya, 2007). Although most of the
evidence gathered so far indicates that the effects of IL-1 on CNS
neurons are detrimental, recent evidence suggests that under some
circumstances IL-1 may actually be required for the normal physiologi-
cal regulation of hippocampal function (Avital et al., 2003). Indeed,
impairment of IL-1 signaling results in a reduced size of dendritic
spines on hippocampal pyramidal neurons (Goshen & Yirmiya, 2009).
Also, application of IL-10 to hippocampal neurons has been shown to
induce synapse formation (Lim et al., 2013). Taken together, the
increase we observed in the secretion of IL-1α and IL-10 in p75−/−
mice might at least in part contribute to the rescuing of neuronal
structure upon T. gondii infection.
The multifunctional cytokine IL-6 was reported to be a promotor
and inhibitor of inflammation (Scheller, Chalaris, Schmidt-Arras, &
Rose-John, 2011; Tilg, Dinarello, & Mier, 1997; Xing et al., 1998) and
has been associated with a variety of neurodegenerative disorders
including Alzheimer's and Parkinson disease (Dobbs et al., 1999;
Wood et al., 1993). IL-6 was also found to induce neuroprotection
and prevent neuron and oligodendrocyte degradation (Chucair-Elliott
et al., 2014; Pizzi et al., 2004), thus contributing to its multifunctional
aspects. Accordingly, our data showed an increased secretion of IL-6
by Ly6Cint brain DCs and Ly6Clow macrophages, supporting these pre-
vious findings.
BDNF signaling has been shown to positively modulate dendritic
and spine architecture in cortical and hippocampal neurons as well as
structural plasticity both in vitro and in vivo (Kellner et al., 2014;
Rauskolb et al., 2010; Zagrebelsky & Korte, 2014). We performed
Western blot analysis of brain homogenates to compare BDNF pro-
tein levels. Here, we found that BDNF levels remained unaltered upon
infection for both WT and p75−/− mice. Interestingly, the precursor
protein proBDNF was strongly increased upon infection. Particularly,
signaling of proBDNF via the p75NTR has been shown to promote
spine pruning and to negatively affect dendritic spine density and syn-
aptic plasticity (Orefice, Shih, Xu, Waterhouse, & Xu, 2016; Qiao, An,
Xu, & Ma, 2017; Yang et al., 2014). In addition, our data imply that
activated immune cells contribute to proBDNF production upon
infection-induced inflammation since previous studies also observed
the secretion of proBDNF by peripheral macrophages under certain
inflammatory conditions (Luo et al., 2016; Wong et al., 2010). Thus,
activated resident or recruited immune cells entering the CNS from
the periphery during neuroinflammation possibly contribute to the
elevated proBDNF levels in the CNS. Our results suggest that the res-
cue of the Toxoplasma infection-induced alterations of neuronal archi-
tecture observed in p75−/− animals may be due to the absence of
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proBDNF-mediated signaling in neurons in combination with the
altered immune response. Yet, it is not clear whether other cell types
are also involved in this observed rescue of neuronal morphology. A
study published by Cragnolini, Huang, Gokina, and Friedman (2009)
demonstrated that astrocytes are capable of expressing p75NTR upon
seizures. Unfortunately, this study only addressed the impact of NGF
on p75NTR signaling, leaving the effect of proneurotrophins on astro-
cyte activation unraveled. Accordingly, as for mature neurotrophins,
only little is known about the final role of proneurotrophins in immune
cell activation. Of note, two studies conducted on peripheral macro-
phages pointed out that proneurotrophins are able to alter the migra-
tory behavior and phenotype of these cells (Williams, Killebrew, Clary,
Seawell, & Meeker, 2015; Wong et al., 2010). Although the altered
phenotype of immune cells in p75−/− mice could be caused by the lack
of proneurotrophin signaling, it remains unclear why cytokine expres-
sion was different in recruited myeloid cells but not in microglia. In
addition, the question arises whether the high levels of proBDNF in
infected peripheral immune cells can also mediate the activation of
myeloid cells before entering the CNS. To this end, further experi-
ments need to be carried out addressing the effect of mature neuro-
trophins and their precursor forms on immune cell activation in the
brain and periphery during steady state and upon inflammatory
conditions.
Taken together, our data provide evidence that neurotrophin sig-
naling via the p75NTR alters innate immune cell behavior and contrib-
utes to function and structural rearrangements in the neuronal network
upon chronic Toxoplasma infection-induced neuroinflammation.
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